Order intake in 2015
Sales in 2015
1Excluding restructuring costs.
Net result in 2015 (in CHF)
1Excluding impairments, restructuring costs, amortization of acquired intangibles (from Metco, net of tax) and results from discontinued operations.
Operating cash flow1
1Before changes in net current assets.
Earnings per share in 20151
1Based on normalized net result.
Dividend proposal for 2015
|in CHF million||January 1 to December 31, 2015||January 1 to December 31, 2014|
|Order intake1||2 537||2 647|
|Sales1||2 671||2 825|
|– as % of sales||12.7 %||16.8 %|
|– as % of sales||-11.4 %||11.4 %|
|Result from continuing operations2||-402||222|
|Result from discontinued operations, net of income taxes2, 6||–16||–20|
|– as % of equity attributable to shareholders of the parent||-27 %||9 %|
|Cash flow from operating activities7||289||256|
|Capital expenditure for property, plant and equipment and intangible assets1||150||151|
|Total assets||4 097||4 966|
|Equity attributable to shareholders of the parent||1 554||2 188|
|– as % of total assets||38 %||44 %|
|Net cash3, 8||79||114|
|Net operating assets1, 9||1 875||2 486|
|Number of employees1||13 723||14 039|
|Research and development expenditure1, 10||103||96|
12015 continuing operations, 2014 restated.
32015 continuing operations, 2014 as reported.
4Includes one-time effects of CHF -112 million (restructuring).
5Includes one-time effects of CHF -588 million (restructuring expenses of CHF -112 million and impairment losses of CHF -476 million).
6Includes reclassification of translation differences amounting to CHF -21 million (previous year: CHF 0 million).
7Cash flow from operating activities before changes in net current assets amounts to CHF 393 million (previous year: CHF 427 million).
8Net cash includes cash and cash equivalents and marketable securities less current and non-current debt.
9Net operating assets include current and non-current operating assets (including goodwill and brands and excluding cash and cash equivalents, current financial investments, current income tax receivables and deferred tax assets) less operating liabilities (excluding current loans and borrowings, non-current financial liabilities, current income tax payables and deferred tax liabilities).
10Research and development expenditure includes expenses recognized as intangible assets in the amount of CHF 22 million (previous year, restated: CHF 12 million).
|in CHF||January 1 to December 31, 2015||January 1 to December 31, 2014|
|Share price||Year high||12.70||15.65|
|Shares outstanding at year-end||339 758 576||339 758 576|
|Market capitalization at year-end in CHF million||3 041||4 247|
|EBIT per share2||-0.90||0.96|
|Earnings per share (reported)||-1.24||0.59|
|Earnings per share3||0.61||0.59|
|Cash flow from operating activities per share||0.85||0.76|
|Equity per share4||4.58||6.50|
|Dividend per share||0.305||0.306|
1Average number of shares with voting and dividend rights (undiluted).
22015 continuing operations, 2014 restated.
32015 based on normalized net result, 2014 reported.
4Attributable to shareholders of the parent.
5Dividend proposal for 2015, to be paid in 2016.
6For financial year 2014, paid in 2015.